•
RP
RPTX
Repare Therapeutics Inc. Common Shares
yahooPHARMACEUTICAL PREPARATIONS
--
Price Chart
Market Cap
111.65M
Volume
935.00K
52W High
$2.66
52W Low
$0.89
Open
$0.00
Prev Close
$2.58
Day Range
0.00 - 0.00
About Repare Therapeutics Inc. Common Shares
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.
Latest News
Repare Therapeutics Stock Rises As Gilead Secures Cancer Asset For $30 Million
Benzinga•Dec 24
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--RPTX, FRGE, CSGS, FIZN
Benzinga•Dec 17
Halper Sadeh LLC Encourages RPTX, THS, RMBI Shareholders to Contact the Firm to Discuss Their Rights
GlobeNewswire Inc.•Nov 27
HAPPY THANKSGIVING AND $HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger – RPTX, AXTA, WTG and SEMR
GlobeNewswire Inc.•Nov 27
Repare Therapeutics Agrees To Acquisition As Board Cites Best Path For Stakeholder Value
Benzinga•Nov 17
Companion Diagnostic Markets Report 2025-2029: Diagnostic Firms Jockey for Position as Pharmaceutical Partnerships Flourish, Discover the Impact of AI
GlobeNewswire Inc.•Jun 6
CNL’S CNRI-H Program Continues Strong Growth Thanks to New Projects With Repare Therapeutics and Defence Therapeutics
GlobeNewswire Inc.•Jan 20
Repare (RPTX) Up 14% as Ovarian Cancer Combo Gets Fast Track Tag
Zacks Investment Research•Jun 6